American Journal of Preventive Medicine
Volume 38, Issue 5 , Pages 525-533 , May 2010

Geographic Disparity, Area Poverty, and Human Papillomavirus Vaccination

  • Sandi L. Pruitt, PhD, MPH

      Affiliations

    • Division of Health Behavior Research, Washington University School of Medicine, Saint Louis, Missouri
    • Corresponding Author InformationAddress correspondence to: Sandi L. Pruitt, PhD, MPH, Washington University School of Medicine Division of Health Behavior Research, 4444 Forest Park Avenue, Suite 6700, Campus Box 8504, Saint Louis MO 63108
    • ,
  • Mario Schootman, PhD

      Affiliations

    • Division of Health Behavior Research, Washington University School of Medicine, Saint Louis, Missouri
    • Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri

References 

  1. American Cancer Society. Cancer Facts and Figures 2009. 2009;
  2. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342–362
  3. Benard VB, Johnson CJ, Thompson TD, et al. Examining the association between socioeconomic status and potential Human Papillomavirus-associated cancers. Cancer. 2008;113(10S):2910–2918
  4. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687–691
  5. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer. 2004;101(5):1051–1057
  6. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93
  7. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the U.S., 1998–2003. Cancer. 2008;113(10S):2855–2864
  8. Benjamins MR, Kirby JB, Bond Huie SA. County characteristics and racial and ethnic disparities in the use of preventive services. Prev Med. 2004;39(4):704–712
  9. Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with healthcare access among U.S. women, 2002. Soc Sci Med. 2008;66(2):260–275
  10. Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer. 2006;106(3):664–669
  11. Nelson DE, Bolen J, Marcus S, Wells HE, Meissner H. Cancer screening estimates for U.S. metropolitan areas. Am J Prev Med. 2003;24(4):301–309
  12. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the U.S.: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–1540
  13. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across U.S. communities. J Epidemiol Community Health. 2006;60(3):202–207
  14. U.S. Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm
  15. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24
  16. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57(1):7–28
  17. Advisory Committee on Immunization Practices Vaccines for Children Program. Resolution No010/09-1: Vaccines to prevent Human Papillomavirus. www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/1009hpv-508.pdf
  18. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13–17 years—U.S., 2007. MMWR Morb Mortal Wkly Rep. 2008;57(40):1100–1103
  19. Grant D, Kravitz-Wirtz N, Breen N, Tiro JA, Tsui J. One in four California adolescent girls have had human papillomavirus vaccination. Los Angeles CA: University of California Los Angeles Center for Health Policy Research; 2009;
  20. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13–17 years—U.S., 2008. MMWR Morb Mortal Wkly Rep. 2009;58(36):997–1001
  21. Saslow D, Wheeler CM. Human papillomavirus vaccines: who will pay, who will receive, when to administer?. Ethn Dis. 2007;17(2S 2):S2–8–13
  22. Lee GM, Santoli JM, Hannan C, et al. Gaps in vaccine financing for underinsured children in the U.S.. JAMA. 2007;298(6):638–643
  23. National, state, and local area vaccination coverage among children aged 19–35 months—U.S., 2007. MMWR Morb Mortal Wkly Rep. 2008;57(35):961–966
  24. Findley SE, Irigoyen M, Stockwell MS. Changes in childhood immunization disparities between central cities and their respective states, 2000 versus 2006. J Urban Health. 2008;86(2):183–195
  25. Middleman AB. Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative. J Adolesc Health. 2004;34(5):414–419
  26. Wooten KG, Luman ET, Barker LE. Socioeconomic factors and persistent racial disparities in childhood vaccination. Am J Health Behav. 2007;31(4):434–445
  27. CDC. 2008 behavioral risk factor surveillance system Survey data. Atlanta GA: USDHHS, CDC; 2008;
  28. CDC. Overview: BRFSS 2008. www.cdc.gov/brfss/technical_infodata/surveydata/2008.htm
  29. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–114
  30. Chao C, Slezak JM, Coleman KJ, Jacobsen SJ. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009;99(6):1137–1142
  31. Christian WJ, Christian A, Hopenhayn C. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health. 2009;44(5):437–445
  32. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes Control. 2007;18(6):627–634
  33. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008;111(5):1103–1110
  34. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3):239–245
  35. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of U.S. socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471–482
  36. Singh GK, Miller BA, Hankey BF, Edwards BK. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975–1999. Bethesda MD: National Cancer Institute; 2003;Report No.: NIH Publication No. 03-0000
  37. Rabash J, Charlton C, Browne WJ, Healy M, Cameron B. MLwiN Version 2.11. Centre for Multilevel Modelling, University of Bristol; 2009;
  38. Snijders TAB, Bosker R. Multilevel analysis (An introduction to basic and advanced multilevel modeling). Thousand Oaks CA: Sage; 1999;
  39. CDC. Survey data and documentation: BRFSS weighting formula. www.cdc.gov/BRfss/technical_infodata/weighting.htm
  40. Larsen K, Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol. 2005;161(1):81–88
  41. Larsen K, Petersen JH, Budtz-Jorgensen E, Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics. 2000;56(3):909–914
  42. CDC. VFC: eligibility criteria. www.cdc.gov/vaccines/programs/vfc/providers/elig-scrn-rec-doc-req.htm
  43. Pickett KE, Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. J Epidemiol Community Health. 2001;55(2):111–122
  44. Pruitt SL, Shim MJ, Mullen PD, Vernon SW, Amick BC. The association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2579–2599
  45. Robert SA. Socioeconomic position and health: the independent contribution of community socioeconomic context. Ann Rev Sociol. 1999;25:489–516
  46. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live?. Pediatrics. 2004;114(1):187–195
  47. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008;46(2):87–98
  48. Rothman SM, Rothman DJ. Marketing HPV vaccine: implications for adolescent health and medical professionalism. JAMA. 2009;302(7):781–786
  49. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–471
  50. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS. 2003;14(5):300–306
  51. De Soto J. Should HPV vaccination be mandatory?. J Fam Pract. 2007;56(4):267–268
  52. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther. 2007;82(6):760–763
  53. Orenstein WA, Hinman AR. The immunization system in the U.S.—the role of school immunization laws. Vaccine. 1999;17(S 3):S19–S24
  54. Morita JY, Ramirez E, Trick WE. Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students. Pediatrics. 2008;121(3):e547–e552
  55. Katz ML, Reiter PL, Kluhsman BC, et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine. 2009;27(24):3195–3200

PII: S0749-3797(10)00095-4

doi: 10.1016/j.amepre.2010.01.018

American Journal of Preventive Medicine
Volume 38, Issue 5 , Pages 525-533 , May 2010

Article Tools